CVS Health Corporation Issues and Sold 5.400% Senior Notes Due 2029, 5.550% Senior Notes Due 2031, 5.700% Senior Notes Due 2034, 6.000% Senior Notes Due 2044 and 6.050% Senior Notes Due 2054

On May 9, 2024, CVS Health Corporation issued and sold $1,000,000,000 aggregate principal amount of the company?s 5.400% Senior Notes due 2029 (2029 Notes), $1,000,000,000 aggregate principal amount of the company?s 5.550% Senior Notes due 2031 (2031 Notes), $1,250,000,000 aggregate principal amount of the company?s 5.700% Senior Notes due 2034 (2034 Notes), $750,000,000 aggregate principal amount of the company?s 6.000% Senior Notes due 2044 (2044 Notes), and $1,000,000,000 aggregate principal amount of the Company?s 6.050% Senior Notes due 2054 (Notes). The Notes were offered pursuant to the Company?s Registration Statement on Form S-3ASR, File No. 333-272200, dated May 25, 2023 (the ?Registration Statement?).

The Notes are governed by and issued pursuant to a Senior Indenture dated August 15, 2006 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the ?Senior Indenture?). The Company may issue additional senior debt securities from time to time pursuant to the Senior Indenture.